Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · operational-macro

APIIC Launches New Supply Chain Fragility Index, Finds A Fifth Of Drugs At Significant Risk

6 October 2026 · By · Wire by Fusion42

Published

6 October 2026

Topic

operational-macro

◆ Sectors

Health

◆ Geography

United States

◆ Source

Read at insidehealthpolicy.com →

◆ Verified

Fusion42 · 6 October 2026 · Fusion42 review

APIIC has introduced a Supply Chain Fragility Index revealing that 20% of drugs are at significant risk due to supply chain vulnerabilities, including drugs frequently facing long-term shortages and lacking sufficient domestic production despite US-based manufacturers.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

You must prepare for disruption as a fifth of drugs face supply chain risks highlighted by this new index. Secure your sourcing and consider domestic alternatives to avoid shortages impacting your product availability.

◆ Coverage

1 source · 6 Oct 2026

◆ Related on Wire

◆ Topics

Healthsupply-chaindrug-shortagedomestic-productionhealthcareregulatory-risk